Clinical Trials Browser

Bites and Stings × pembrolizumab × 1 year × Clear all

NCT03319940 2025-11-19

Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)

Phase 1 Active not recruiting

Bites and Stings, Neoplasms, Small Cell Lung Carcinoma

NCT03792841 2025-10-16

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Phase 1 Terminated

Bites and Stings, Prostatic Neoplasms